BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30632009)

  • 1. Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study.
    Si P; Zhang P; Chen T; Liu G; Lu H; Chen H; Wang C; Zhai B; Li W
    Clin Transl Oncol; 2019 Aug; 21(8):1085-1092. PubMed ID: 30632009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
    Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
    JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
    Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.
    Ariyan C; Brady MS; Gönen M; Busam K; Coit D
    Ann Surg Oncol; 2009 Jan; 16(1):186-90. PubMed ID: 18979135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
    Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
    Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.
    Holtkamp LH; Wang S; Wilmott JS; Madore J; Vilain R; Thompson JF; Nieweg OE; Scolyer RA
    Ann Surg Oncol; 2015 Sep; 22(9):2972-7. PubMed ID: 25990968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival.
    Ebner F; Wöckel A; Janni W; Kreienberg R; Schwentner L; Wischnewsky M
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1823-1831. PubMed ID: 28439713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of sentinel lymph node metastasis status in predicting the presence of residual disease in the non-sentinel lymph node of breast cancer patients].
    Yang B; Yang L; Zuo WS; Ge WK; Wang YS; Zheng G; Zheng MZ; Yu ZY
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1072-5. PubMed ID: 23902839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients.
    Cox C; DuPont EL; Furman B; Stowell N; Clark J; Ebert M; Diaz NM; Cantor A
    Am J Surg; 2003 Oct; 186(4):333-6. PubMed ID: 14553845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement.
    Shigematsu H; Taguchi K; Koui H; Ohno S
    Ann Surg Oncol; 2015 Jul; 22(7):2365-71. PubMed ID: 25476029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.